Centene Corporation CNC
70.40 USD -0.08 (-0.11%)
Nov 12, 2026, 12:04 PM EST
68.47 Day range 70.79
31.80 52-week range 76.01
- YTD
- +71.08%
- 1 year
- +94.48%
News
prnewswire.com Meridian Health Plan of Illinois Announces Nearly $1.2M Partnership with March of Dimes for Local Maternal Healthcare Initiatives Funding will Support the Delivery of Medical Services, Resources, and Health Awareness for Moms-to-be through Community Events and a Newly Funded Mobile Unit CHICAGO, Nov. 10, 2026 /PRNewswire/ --…
fool.com Obamacare Subsidies Lapsed. Here's Why Health Insurer Stocks Are Watching the New Congress. More government subsidies for households to pay for health insurance may be introduced, which could help grow Obamacare premiums.
247wallst.com Hospital Stocks Soared as Democrats Took Congress HCA posted its biggest one-day jump in four years before a single law changed. Wall Street is pricing in relief that needs Congress, a presidential signature, and a December funding fight to survive.
zacks.com Midterm Results Put These 4 Renewable, Healthcare & AI Stocks in Focus Midterm election results are reshaping sector sentiment, putting Nextpower, Centene & AI infrastructure companies in focus amid shifting policy expectations.
zacks.com Centene Corporation (CNC) Hits Fresh High: Is There Still Room to Run? Centene (CNC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
businesswire.com US Department of Justice Intervenes in Health Insurance Whistleblower Lawsuit Brought by Lieff Cabraser Against Centene Corporation NASHVILLE, Tenn.--(BUSINESS WIRE)-- #Centene--US Department of Justice Intervenes in Health Insurance Whistleblower Lawsuit Brought by Lieff Cabraser Against Centene Corporation.
benzinga.com Here's How Much $100 Invested In Centene 15 Years Ago Would Be Worth Today Centene (NYSE:CNC) has outperformed the market over the past 15 years by 2.4% on an annualized basis producing an average annual return of 15.29%. Currently, Centene has a market capitalization of…
benzinga.com Truist Securities Reiterates Buy on Centene, Raises Price Target to $82 Truist Securities analyst David Macdonald reiterates Centene (NYSE:CNC) with a Buy and raises the price target from $80 to $82.
benzinga.com Wells Fargo Maintains Equal-Weight on Centene, Raises Price Target to $75 Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Equal-Weight and raises the price target from $69 to $75.- benzinga.com JP Morgan Maintains Neutral on Centene, Raises Price Target to $75 JP Morgan analyst John Stansel maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $67 to $75.
benzinga.com Morgan Stanley Maintains Equal-Weight on Centene, Raises Price Target to $71 Morgan Stanley analyst Ricky Goldwasser maintains Centene (NYSE:CNC) with a Equal-Weight and raises the price target from $66 to $71.- benzinga.com Barclays Maintains Overweight on Centene, Raises Price Target to $82 Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $80 to $82.
benzinga.com Coca-Cola To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday Analysts cut targets for Itron, Whirlpool, Enphase and Ultra Clean; raised PayPal, Roblox and SoFi targets. Whirlpool downgraded to Sell.
benzinga.com Centene Analysts Boost Their Forecasts Following Upbeat Q3 Earnings Centene beats Q3 estimates, raises 2026 earnings and sales guidance; analysts lift price targets despite shares dipping premarket.
benzinga.com Cantor Fitzgerald Maintains Overweight on Centene, Raises Price Target to $79 Cantor Fitzgerald analyst Sarah James maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $75 to $79.
benzinga.com B of A Securities Maintains Buy on Centene, Raises Price Target to $82 B of A Securities analyst Kevin Fischbeck maintains Centene (NYSE:CNC) with a Buy and raises the price target from $80 to $82.
benzinga.com Centene Stock Approaches 52-Week High on Faster-Than-Expected Earnings Recovery Centene reports Q3 adjusted EPS of 58 cents on $50.65B in revenue, beating forecasts and raising full-year 2026 guidance despite Medicaid membership drops.
benzinga.com Centene Q3 2026 Earnings Call Transcript Centene (NYSE:CNC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com UPDATE: Centene FY2026 Adj EPS expected to be more than $5.20 vs $4.88 Est; Raises FY2026 Sales Guidance from $193.500B-$197.500B to $196.500B-$200.500B vs $196.334B Est Centene (NYSE:CNC) FY2026 expected to be more than $5.20 vs $4.88 Est. raises FY2026 sales outlook from $193.500 billion-$197.500 billion to $196.500 billion-$200.500 billion vs $196.334 billion…
benzinga.com Centene Q3 Adj. EPS $0.58 Beats $0.10 Estimate, Sales $50.647B Beat $47.114B Estimate Centene (NYSE:CNC) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $0.10 by 480 percent. This is a 16 percent increase over earnings of $0.50 per share…- benzinga.com Centene To Launch Its National Performance-Based Gold Card Program In November 2026 The program, which will initially be available to more than 160,000 qualifying providers nationwide for select outpatient services, is designed to streamline the prior authorization review process…
benzinga.com Junk Bond Yields Are Back Above 15%: 10 Stocks In The Pressure Zone Junk bond yields surpassed 15%, the highest since 2022. These 10 stocks with bonds in XCCC carry $97 billion of debt as higher rates bite.- benzinga.com Centene Reaffirms FY26 Adjusted Diluted EPS Guidance Of Greater Than $4.80 September 16, 2026, at 9:00 a.m. EDT. During the conference, and in subsequent discussions with investors continuing through the week of September 21, members of management will discuss the Company's…
benzinga.com Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
benzinga.com Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.
benzinga.com Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’ Mark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.- benzinga.com JP Morgan Maintains Neutral on Centene, Raises Price Target to $67 JP Morgan analyst John Stansel maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $60 to $67.
- benzinga.com Bernstein Maintains Outperform on Centene, Raises Price Target to $79 Bernstein analyst Lance Wilkes maintains Centene (NYSE:CNC) with a Outperform and raises the price target from $68 to $79.
- benzinga.com Barclays Maintains Overweight on Centene, Raises Price Target to $80 Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $75 to $80.
benzinga.com Centene Finds Profit Growth Even as Medicaid Membership Softens Centene beat Q2 earnings and revenue estimates, raised its 2026 outlook, improved medical cost trends, and reported lower Medicaid membership.
benzinga.com Centene FY2026 Adj EPS expected to be more than $4.80 vs $3.52 Est; Raises FY2026 Sales Guidance from $187.500B-$191.500B to $193.500B-$197.500B vs $191.020B Est Centene (NYSE:CNC) FY2026 expected to be more than $4.80 vs $3.52 Est. raises FY2026 sales outlook from $187.500 billion-$191.500 billion to $193.500 billion-$197.500 billion vs $191.020 billion…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Molina Healthcare Stung By Membership Decline, Stocks Sinks 12% Molina Healthcare (MOH) reported Q2 earnings of $1.51 per share, beating estimates. Shares fell on lower premium revenue and membership.
benzinga.com Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It Starting in December 2026, millions of Medicaid enrollees will have to prove they still qualify twice as often as they do today, and the Urban Institute estimates the change could push 2 to 3.1…
benzinga.com Elevance Health's Small Outlook Boost Disappoints, Stock Sinks Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.
benzinga.com Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales guidance. Other stocks also down in pre-market.- benzinga.com TD Cowen Maintains Hold on Centene, Raises Price Target to $65 TD Cowen analyst Ryan Langston maintains Centene (NYSE:CNC) with a Hold and raises the price target from $47 to $65.
- benzinga.com Truist Securities Maintains Buy on Centene, Raises Price Target to $78 Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $71 to $78.
benzinga.com Wells Fargo Maintains Equal-Weight on Centene, Raises Price Target to $69 Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Equal-Weight and raises the price target from $56 to $69.- benzinga.com RBC Capital Maintains Sector Perform on Centene, Raises Price Target to $71 RBC Capital analyst Ben Hendrix maintains Centene (NYSE:CNC) with a Sector Perform and raises the price target from $70 to $71.
benzinga.com Obamacare Premiums Could Jump 14% in 2027 As Insurers Warn Rising Medical Costs are Driving Rates Higher Obamacare Insurers Seek 14% Premium Increase for 2027 as Medical Costs Rise- benzinga.com Cantor Fitzgerald Maintains Overweight on Centene, Raises Price Target to $75 Cantor Fitzgerald analyst Sarah James maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $60 to $75.
benzinga.com 8 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com RBC Capital Initiates Coverage On Centene with Sector Perform Rating, Announces Price Target of $70 RBC Capital analyst Ben Hendrix initiates coverage on Centene (NYSE:CNC) with a Sector Perform rating and announces Price Target of $70.- benzinga.com If You Invested $100 In Centene Stock 20 Years Ago, You Would Have This Much Today
benzinga.com Membership Slump Forces Health Giant Centene Into Staff Buyouts: Report Facing shrinking health plan enrollment, Centene Corp. (CNC) will offer voluntary buyouts to employees as part of a major cost-cutting plan.- benzinga.com 'Centene Offers Most Staff Buyouts After Obamacare Member Losses' - Bloomberg https://www.bloomberg.com/news/articles/2026-06-15/centene-offers-buyouts-to-employees-job-layoffs-could-follow